These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6276701)

  • 21. Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
    Mintz L; Drew WL
    Antimicrob Agents Chemother; 1981 Feb; 19(2):332-4. PubMed ID: 6289731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
    Lang SD; Edwards DJ; Durack DT
    Antimicrob Agents Chemother; 1980 Mar; 17(3):488-93. PubMed ID: 6252831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro antagonism by N-formimidoyl thienamycin and cefoxitin of second and third generation cephalosporins in Aeromonas hydrophila and Serratia marcescens.
    Miller MA; Finan M; Yousuf M
    J Antimicrob Chemother; 1983 Apr; 11(4):311-8. PubMed ID: 6343337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The comparative activities of N-formimidoyl theinamycin (MK0787), moxalactam, cefotaxime and cefoperazone against Yersinia enterocolitica and Listeria monocytogenes.
    Ahonkhai VI; Sierra MF; Cherubin CE; Shulman MA
    J Antimicrob Chemother; 1982 May; 9(5):411-2. PubMed ID: 6284696
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species].
    Schröter G; Schrettenbrunner A; Strenzel I
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp.
    Livingston WK; Elliott AM; Cobbs CG
    Antimicrob Agents Chemother; 1981 Jan; 19(1):114-6. PubMed ID: 6787975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.
    Cullmann W; Opferkuch W; Stieglitz M; Werkmeister U
    Antimicrob Agents Chemother; 1982 Aug; 22(2):302-7. PubMed ID: 6821459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods.
    O'Donnell ED; Freimer EH; Gilardi GL; Raeder R
    Antimicrob Agents Chemother; 1982 Apr; 21(4):673-5. PubMed ID: 6211143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of moxalactam and cefoperazone against Streptococcus pneumoniae with differing susceptibilities to penicillin.
    Tarpay MM; Welch DF; Marks MI
    Chemotherapy; 1982; 28(4):261-6. PubMed ID: 6214382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro efficacy of cefoperazone compared with cefotaxime, LY127935, and thienamycin.
    Lang SD; Durack DT
    Clin Ther; 1980; 3(Spec Issue):112-6. PubMed ID: 6248219
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro comparative activity of moxalactam, GR 20263, and N-formimidoyl thienamycin to other beta-lactam antibiotics and tobramycin against enterobacteriaceae and staphylococci.
    Cynamon MH; Granato PA
    Chemotherapy; 1982; 28(3):204-8. PubMed ID: 6212205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The new cephalosporins and penicillins.
    Weinstein AJ
    Compr Ther; 1982 Feb; 8(2):26-31. PubMed ID: 6279354
    [No Abstract]   [Full Text] [Related]  

  • 33. Susceptibility of group B streptococci to 16 beta-lactam antibiotics, including new penicillin and cephalosporin derivatives.
    Jacobs MR; Kelly F; Speck WT
    Antimicrob Agents Chemother; 1982 Nov; 22(5):897-900. PubMed ID: 6758692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Hanslo D; King A; Shannon K; Warren C; Phillips I
    J Antimicrob Chemother; 1981 Jun; 7(6):607-17. PubMed ID: 6265426
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antibacterial activity of N-formimidoyl-thienamycin in comparison with other beta-lactam antibiotics against clinical problem strains (author's transl)].
    Grimm H
    Arzneimittelforschung; 1982; 32(6):595-7. PubMed ID: 6214262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of Pseudomonas aeruginosa to cefoperazone, cefotaxime and moxalactam, with special reference to isolates resistant to aminoglycosides, carbenicillin and ticarcillin.
    Woolfrey BF; Fox JM; Quall CO
    J Antimicrob Chemother; 1981 Sep; 8(3):205-11. PubMed ID: 6270052
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative effect of beta-lactam activity on Pseudomonas aeruginosa as a function of resistance phenotypes].
    Thabaut A; Philippon A; Meyran M
    Presse Med; 1984 Mar; 13(13):768-71. PubMed ID: 6231592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The in-vitro activity of mezlocillin against community hospital isolates in comparison to other penicillins and cephalosporins.
    Parry MF; Folta D
    J Antimicrob Chemother; 1983 May; 11 Suppl C():97-102. PubMed ID: 6619043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superior activity of N-formimidoyl thienamycin against gentamicin-resistant Pseudomonas aeruginosa.
    Michael PR; Alford RH; McGee ZA
    Antimicrob Agents Chemother; 1981 Nov; 20(5):702-4. PubMed ID: 6798926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins.
    Cynamon MH; Palmer GS
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1079-81. PubMed ID: 6961887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.